| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.07 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.091 | 0.08 |